Hyaluronan coated cerium oxide nanoparticles modulate CD44 and reactive oxygen species expression in human fibroblasts

J Biomed Mater Res A. 2016 Jul;104(7):1736-46. doi: 10.1002/jbm.a.35704. Epub 2016 Mar 21.

Abstract

Cerium oxide nanoparticles are being widely explored for cell therapies. In this study, nanoceria was functionalized with hyaluronan (HA) using the organosilane linker, 3-aminopropyltriethoxysilane. HA-nanoceria was found to be cytocompatible and to reduce intracellular reactive oxygen species in human fibroblasts. The HA-nanoceria was found to colocalize with CD44 on the surface of the cells and once internalized traffic to the lysosomes, be degraded and induce markers of autophagy. These particles were also effective in reducing the cell surface expression of CD44. Together these data suggest that HA-nanoceria is a promising drug delivery material to target CD44-expressing cells through a variety of mechanisms. © 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 104A: 1736-1746, 2016.

Keywords: CD44; cerium oxide; hyaluronan; nanoparticle.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Communication / drug effects
  • Cell Line
  • Cell Proliferation / drug effects
  • Cerium / chemistry*
  • Coated Materials, Biocompatible / pharmacology*
  • Fetus / cytology
  • Fibroblasts / cytology
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism*
  • Flow Cytometry
  • Humans
  • Hyaluronan Receptors / metabolism*
  • Hyaluronic Acid / pharmacology*
  • Intracellular Space / metabolism
  • Lung / cytology
  • Lysosomes / drug effects
  • Lysosomes / metabolism
  • Nanoparticles / chemistry*
  • Nanoparticles / ultrastructure
  • Reactive Oxygen Species / metabolism*
  • Spectroscopy, Fourier Transform Infrared
  • Thermogravimetry

Substances

  • Coated Materials, Biocompatible
  • Hyaluronan Receptors
  • Reactive Oxygen Species
  • Cerium
  • ceric oxide
  • Hyaluronic Acid